Krystal Biotech, Inc. ( KRYS) - Stock Earnings
KRYS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 51.4 million USD | 107.1 million USD |
| 2026Q1 | 55.9 million USD | 116.4 million USD |
| 2026Q2 | 54.8 million USD | 119.2 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
KRYS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 10.9 million USD | 50.7 million USD |
| 2024 | 89.2 million USD | 290.5 million USD |
| 2025 | 204.8 million USD | 389.1 million USD |
| 2026 Est. | — | — |
KRYS
Price: $332.27
52 week price:
Earnings Per Share: 7.97 USD
P/E Ratio: 40.96
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 151900
Ebitda: -2.1 millionMarket Capitalization: 9.7 billion